1:10 Stock Split Ahead: Multibagger Pharma Stock Revises Record Date; 483% Returns In 6 Months

Sudarshan Pharma Industries Ltd., a small-cap specialty chemical company based in Mumbai, has announced a 1:10 stock split after an impressive 403% surge in its share price this year. The stock split intends to increase liquidity and make the shares more affordable for small investors. The record date for the stock split was initially set for November 18, which has now been revised to November 23, 2024, due to administrative adjustments.

Sudarshan Pharma Stock Split:

As per the latest announcement by the company's board, the face value of the equity shares will undergo sub-division and will be reduced from Rs. 10 to Rs. 1 per share, effectively increasing the total number of shares ten times without having any impact on the company's overall valuation and would potentially attract a broader investor base and enhance the stock's liquidity in the market.

The stock split ratio is 1:10. For determining eligible shareholders, the company has revised the record date to November 23. Earlier, the record date was set on November 18.

This means that only those shareholders will be eligible who are holding Sudarshan shares by the end of the record date in their demat account.

Sudarshan Pharma Share Price:

Sudarshan Pharma Industries Limited has seen a remarkable rally in its share prices over the past six months, making it among the outstanding performers in the small-cap pharma sector. Also, Sudarshan becomes one of the top 2024 multi-baggers.

The stock price has increased by an impressive 483.41% in a six-month span. While its year-to-date (YTD) performance is with gains of 403.54%.

With that, the stock has given impressive returns. For instance, if an investor bought Sudarshan Pharma stock for Rs 50,000 on May 9th, when it traded at Rs 69.92. By the end of November 9, 2024, the stock had skyrocketed by 483.41%. That being said, Rs 50,000 investment bags return worth Rs 2,41,705, taking its total corpus to Rs 2,91,705.

Last month, in its note, brokerage Ventura Securities highlighted that with its recent stock split announcement and strategic expansions in the pharmaceutical sector, Sudarshan Pharma has positioned itself as a strong contender in the market. Investors seeking to invest in stocks should keep a close eye on the company's ongoing developments, as its recent performance and upcoming stock split indicate potential for long-term growth.

About Sudarshan Pharma:

Mumbai-based Sudarshan Pharma Industries Pvt. Ltd. was founded in 2008. The company went public in 2016 and was officially listed on the stock exchange. As mentioned on SPIL's website, the company currently has a diverse business portfolio, focusing on the pharmaceutical sector and specialty chemicals. The company manufactures specialty chemicals and intermediates used in various industries, including pharma, paints, food, and adhesives. Sudarshan Pharma has a presence both in India and in global markets, as its products are exported to several countries, including the UK, Australia, Uzbekistan, Syria, Oman, Taiwan, and across the MENA region.